Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2026-01-28 @ 11:55 AM
Study NCT ID:
NCT03573050
Status:
COMPLETED
Last Update Posted:
2018-08-21
First Post:
2018-05-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase
Sponsor:
SocraTec R&D GmbH
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Bioequivalence | View |
Keywords: